Arizona
AZHB 1498 (2022) appropriated funding for psilocybin research grants focused on PTSD and related conditions.
Legislation
- HB 1498 (2022)Research-grant framework; implemented by state health authority.
The CodexField ManualLegal Status
Legal Status, United States
Federal law, state-by-state status, and the distinction between decriminalization and legalization — a living reference.
⚠ Not legal advice
This page is an educational summary compiled by the community, not legal advice. Psilocybin law changes frequently; verify the current status with authoritative sources and counsel before acting on anything here. Oldest entry was last reviewed 24 Apr 2026.
§ 01Federal Law
Psilocybin and psilocin are Schedule I controlled substances under the federal Controlled Substances Act of 1970, meaning federal authorities classify them as having no accepted medical use and a high potential for abuse. Both claims are at odds with the clinical literature; the scheduling has not caught up.
Federal law applies in every state, on federal property, and in interstate transport. A state can decide not to enforce possession or cultivation under its own laws — as Oregon and Colorado have — but federal agencies (DEA, FBI, U.S. Postal Inspectors) retain jurisdiction. In practice, federal prosecutions of small-scale personal use have been rare; federal enforcement focuses on trafficking, interstate commerce, and activity on federal land.
Spores themselves — which contain no psilocybin — occupy a narrow federal gap and are legal to possess federally for microscopy purposes, though a handful of states (CA, GA, ID) specifically criminalize them.
§ 02Decriminalization vs. Legalization
Decriminalization
Removes or lowers criminal penalties for specific acts — usually personal possession of small amounts — without legalizing manufacture, sale, or distribution. The substance remains illegal; prosecution is deprioritized. A police officer may still confiscate, and sale is still a crime. Most US municipal reforms have taken this form.
Legalization
Creates an affirmative legal framework under which the substance can be possessed, manufactured, sold, or administered in specified circumstances. Legalization typically includes a regulator, licensed providers, product-safety requirements, and tax or fee structures. Oregon's Measure 109 and Colorado's Proposition 122 are the only US examples to date.
A state or city can do both: legalize regulated therapeutic use while leaving unregulated personal use either decriminalized or prohibited. Oregon is the clearest example.
§ 03State & Territory Status
Medical research Indiana
INHB 1260 (2024) authorized clinical trials at the state's medical institutions.
Legislation
- HB 1260 (2024)Clinical-trial framework; research-only.
Maryland
MDEstablished a Task Force on Responsible Use of Natural Psychedelic Substances; research pathway funded.
Legislation
- SB 709 (2024)Task force + research authorization.
New Mexico
NMSB 219 (2025) established a medical psilocybin advisory board and pathway for qualifying conditions.
Legislation
- SB 219 (2025)Medical Psilocybin Act; advisory board convened.
Texas
TXHB 1802 (2021) authorized psilocybin clinical research for PTSD, targeting veterans.
Legislation
- HB 1802 (2021)Veteran-focused PTSD research program.
Utah
UTSB 266 (2024) established a pilot program allowing qualifying hospitals to administer psilocybin under controlled conditions.
Legislation
- SB 266 (2024)Psilocybin pilot program at participating hospitals.
§Authoritative Trackers
For verification and real-time updates, the trackers below are the standard references. They are independently maintained and track bill progress, municipal reforms, and new research programs faster than this page can.
The codex is maintained by its readers. If an entry on this page is out of date or wrong, the state cards are editable by community contribution — send corrections with a citation.